Dr. Shelley Hwang, MD
Claim this profileDuke University Medical Center
Studies Breast Cancer
Studies Neoadjuvant Therapy
6 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
Stage I
Stage II
2Neoadjuvant Therapy
Affiliated Hospitals
Clinical Trials Shelley Hwang, MD is currently running
Pre-op Pembro + Radiation Therapy
for Breast Cancer
This research trial is studying a combination of neoadjuvant radiotherapy (RT), immunotherapy (pembrolizumab) and chemotherapy for lymph node-positive, triple negative (TN) or hormone receptor positive/HER2-negative breast cancer. The names of the study interventions involved in this study are: * Radiation Therapy (RT) * Immunotherapy: Pembrolizumab (MK-3475) * Chemotherapies: * Paclitaxel * Doxorubicin (also called Adriamycin) * Cyclophosphamide * Carboplatin (optional, and in TN only) * Capecitabine (optional, and in TN only)
Recruiting1 award Phase 219 criteria
Robotic vs. Open Mastectomy
for Breast Cancer
This trial compares the safety and effectiveness of a new robotic surgery tool, the da Vinci SP Surgical System, to traditional open surgery for patients undergoing breast surgery that spares the nipple. The robotic system aims to improve precision and recovery. The da Vinci SP Surgical System is one of the latest versions of robotic surgery systems, designed for minimally invasive procedures.
Recruiting1 award N/A6 criteria
More about Shelley Hwang, MD
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Shelley Hwang, MD has experience with
- LUM Imaging System
- Doxorubicin
- Pembrolizumab
- Cyclophosphamide
- Paclitaxel
- Capecitabine
Breakdown of trials Shelley Hwang, MD has run
Breast Cancer
Neoadjuvant Therapy
Lymph Node Biopsy
Intraductal Papilloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shelley Hwang, MD specialize in?
Shelley Hwang, MD focuses on Breast Cancer and Neoadjuvant Therapy. In particular, much of their work with Breast Cancer has involved Stage I patients, or patients who are Stage II.
Is Shelley Hwang, MD currently recruiting for clinical trials?
Yes, Shelley Hwang, MD is currently recruiting for 2 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Shelley Hwang, MD has studied deeply?
Yes, Shelley Hwang, MD has studied treatments such as LUM Imaging System, Doxorubicin, Pembrolizumab.
What is the best way to schedule an appointment with Shelley Hwang, MD?
Apply for one of the trials that Shelley Hwang, MD is conducting.
What is the office address of Shelley Hwang, MD?
The office of Shelley Hwang, MD is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.